The Latest Breaking News from Vaccine

There are no plans to give the fourth jab to under 50s, NHS England has confirmed

“All this talk about the UK becoming a serious science superpower is b******”

HEALTH chiefs are working to access more vaccines which protect against monkeypox after cases in Scotland rose again.

Public Health Scotland (PHS) said there have now been 79 laboratory confirmed cases of the disease.

"Comments such as this are not just hurtful, they are also deeply unhelpful."

Rates of new cases are declining in major cities, suggesting public health campaigns are working.

The U.S. Food and Drug Administration (FDA) has approved Incyte’s (NASDAQ:INCY) Pemazyre (pemigatinib), a selective fibroblast growth factor receptor (FGFR) inhibitor, for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with FGFR1 rearrangement. Incyte shares traded in a range of $71.38 to $72.98 on day volume of 1.25…

Federal health officials expressed cautious optimism Friday about the trajectory and spread of the monkeypox outbreak, emphasizing that increased vaccination, harm reduction behaviors and educational and outreach efforts appear to be helping to curb the spread.

Washington (AFP) - Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot administered to hundreds of millions around the world.